Cargando…
D-sorbitol can keep the viscosity of dispersive ophthalmic viscosurgical device at room temperature for long term
The combination of 3% sodium hyaluronate (HA) and 4% sodium chondroitin sulfate (CS) is used as a dispersive ophthalmic viscosurgical device (OVD) during cataract surgery. For most OVDs containing HA, storage at 2–8 °C is recommended to preserve product characteristics. In order to develop a dispers...
Autores principales: | Nogami, Eiji, Watanabe, Ippei, Hoshi, Hirotaka, Kasahara, Masakazu, Honda, Naoto, Sato, Miwako, Suzuki, Kiyoshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6856377/ https://www.ncbi.nlm.nih.gov/pubmed/31727999 http://dx.doi.org/10.1038/s41598-019-53390-0 |
Ejemplares similares
-
Addition Of D-Sorbitol Improves The Usability Of Ophthalmic Viscosurgical Devices
por: Watanabe, Ippei, et al.
Publicado: (2019) -
Quantitative Assessment of Ophthalmic Viscosurgical Devices on Visibility, Spreadability, and Durability as Corneal Wetting Agents for the Wet Shell Technique
por: Watanabe, Ippei, et al.
Publicado: (2020) -
Outcomes of a Dispersive Ophthalmic Viscosurgical Device
por: Acar, Banu, et al.
Publicado: (2020) -
Prefilled syringes and usability of ophthalmic viscosurgical devices
por: Shiba, Takuya, et al.
Publicado: (2014) -
Impact of Ophthalmic Viscosurgical Devices in Cataract Surgery
por: Malvankar-Mehta, Monali S., et al.
Publicado: (2020)